Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04099641 |
|---|---|
| Brief Title: | An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients |
| First Submitted : | September 18, 2019 |
| First Submitted that Met QC Criteria : | September 19, 2019 |
| First Posted : | September 23, 2019 |
| Last Update Submitted that Met QC Criteria : | June 14, 2022 |
| Last Update Posted : | June 15, 2022 |